Goal-directed fluid therapy guided by stroke volume variation and cerebral oximetry during cytoreductive surgery with HIPEC: a case report
Gustavo Araújo do Nascimento Santos, Fabrício Tavares Mendonça, Iuri Ferreira Lopes, Grazielle Rodrigues Silva
Abstract
Cytoreduction with hyperthermic intraperitoneal chemotherapy (HIPEC) is a complex surgical procedure used in the treatment of peritoneal tumors, improving patient prognosis. It involves significant anesthetic challenges such as volume loss, thermal fluctuations, and the risk of metabolic complications. Fluid replacement must be individualized and guided by hemodynamic parameters such as stroke volume variation (SVV) and urine output. Monitoring with FloTrac and NIRS allows continuous assessment of fluid responsiveness and cerebral perfusion. Thermal oscillation requires active warming and cooling measures. Altogether, these precautions promote greater safety during the procedure and contribute to better patient outcomes.
Keywords
References
1. Hotza G, Karageorgos M, Pastourmatzi V, Baniowda N, Kyziridis D, Kalakonas A, et al. Morbidity and mortality of patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Discov Oncol. 2024;15(1):106. https://doi.org/10.1007/s12672-024-00968-4. PMid:38580760.
2. Solanki SL, Agarwal V, Ambulkar RP, Joshi MP, Chawathey S, Rudrappa SP, et al. The hemodynamic management and postoperative outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective observational study. Crit Care Res Pract. 2024;2024(1):8815211. https://doi.org/10.1155/ccrp/8815211. PMid:39760061.
3. Hendrix RJ, Damle A, Williams C, Harris A, Spanakis S, Lambert DH, et al. Restrictive intraoperative fluid therapy is associated with decreased morbidity and length of stay following hyperthermic intraperitoneal chemoperfusion. Ann Surg Oncol. 2019;26(2):490-6. https://doi.org/10.1245/s10434-018-07092-y. PMid:30515670.
4. Tuncel Z, Düzgün Ö. The management of goal-directed fluid therapy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Medicine. 2024;103(20):e38187. https://doi.org/10.1097/MD.0000000000038187. PMid:38758894.
5. Biedrzycka A, Lango R. Tissue oximetry in anaesthesia and intensive care. Anaesthesiol Intensive Ther. 2016;48(1):41-8. doi: 10.5603/AIT.2016.0005. PMID: 26966109.
6. Ramirez MF, Guerra-Londono JJ, Owusu-Agyemang P, Fournier K, Guerra-Londono CE. Temperature management during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Front Oncol. 2023;12:1062158. https://doi.org/10.3389/fonc.2022.1062158. PMid:36741691.
7. Chen S, Lin Y, Gao S, Liu S, Yang Z, Ma R, et al. Anesthesia management of CRS and HIPEC in advanced ovarian cancer with ultra-high intra-abdominal pressure: a case report. Front Oncol. 2024;14:1449171. https://doi.org/10.3389/fonc.2024.1449171. PMid:39664174.
8. Solanki SL, Maurya I, Sharma J. Impact of fluid and haemodynamic management in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy on postoperative outcomes - A systematic review. Indian J Anaesth. 2023;67(10):866-79. https://doi.org/10.4103/ija.ija_367_23. PMid:38044912.
9. Lewis AL, Dabo-Trubelja A. Anesthesia for cytoreductive surgery with heated intraperitoneal chemotherapy [Internet]. Waltham (MA): UpToDate Inc.; 2025 [cited 2025 Apr 10]. Available from: https://www.uptodate.com/contents/anesthesia-for-cytoreductive-surgery-with-heated-intraperitoneal-chemotherapy.
10. Sørensen H. Near infrared spectroscopy evaluated cerebral oxygenation during anesthesia. Dan Med J. 2016;63(12):B5318. PMid:27910802.
Submitted date:
12/19/2025
Accepted date:
06/19/2026
Facebook
LinkedIn
Mendeley
Reddit
Email